IL1B and asthma: In a murine model of severe, steroid-resistant asthma triggered by Chlamydia respiratory infection and ovalbumin-induced allergic airway disease, administration of anti-IL-1β antibody and NLRP3 inhibitor (MCC950) suppressed neutrophilic inflammation and reduced IL-1β production in the lung [43].